DIHYDROERGOTAMINE MESYLATE INJECTION USP DIN 02241163
Health Canada record
| Active ingredient(s) | DIHYDROERGOTAMINE MESYLATE 1 MG |
|---|---|
| Dosage form | Liquid |
| Route | Subcutaneous; Intramuscular; Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N02CA01 DIHYDROERGOTAMINE |
| Original market date | 23-Dec-1999 |
| Current status date | 01-Aug-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sandoz Canada Incorporated — licence 101370, currently licensed, last inspection rating C (2025-02-25).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DIHYDROERGOTAMINE MESYLATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00027243 | DIHYDROERGOTAMINE (DHE) | STERIMAX INC | Solution | DIHYDROERGOTAMINE MESYLATE 1 MG | Marketed |
| 02228947 | MIGRANAL NASAL SPRAY 4MG/ML | STERIMAX INC | Liquid | DIHYDROERGOTAMINE MESYLATE 0.5 MG | Marketed |
| 02242411 | PMS-DIHYDROERGOTAMINE | PHARMASCIENCE INC | Liquid | DIHYDROERGOTAMINE MESYLATE 4 MG | Cancelled Pre Market |
| 02242457 | PMS-DIHYDROERGOTAMINE | PHARMASCIENCE INC | Liquid | DIHYDROERGOTAMINE MESYLATE 1 MG | Cancelled Pre Market |
International API supply for DIHYDROERGOTAMINE MESYLATE
4 active FDA Drug Master Files.
Request a quote for DIHYDROERGOTAMINE MESYLATE INJECTION USP